Article metrics
PDF
Other content recommended for you
- Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
- UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
- ▼Natalizumab for multiple sclerosis?
- Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
- The unintended consequences of NICE
- NICE and neurology
- Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
- Diagnosis and disease modifying treatments in multiple sclerosis
- Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
- Disease modifying therapies for relapsing multiple sclerosis